Sonosphere

Company Overview

Snapshot

Founded in April 2023, Sonosphere operates with 1–10 employees and has raised $250,000 across two funding rounds from G.O Innovation. The company is currently in the R&D product stage, focusing on developing its novel peripheral artery diagnosis tool.

Business overview

Sonosphere Medical is developing an innovative tool for peripheral artery diagnosis (PAD/LEAD) and 3D reconstruction of organs. The company's patent-pending technology incorporates an advanced algorithm to create 3D visualizations of arteries, targeting millions of at-risk patients. It operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Diagnostics Devices, and serves the Healthcare and Provider markets.

Company Intelligence Q&A

What is Sonosphere's primary focus?

Sonosphere Medical is developing a novel tool for peripheral artery diagnosis (PAD/LEAD) and 3D reconstruction of organs, utilizing a patent-pending technology to create 3D visualizations of arteries.

When was Sonosphere founded?

Sonosphere was founded in April 2023.

How much capital has Sonosphere raised?

Sonosphere has raised $250,000 across two funding rounds.

What is the current product stage of Sonosphere's technology?

Sonosphere's product is currently in the R&D stage, focusing on developing its novel peripheral artery diagnosis tool.

Which sector does Sonosphere primarily operate in?

Sonosphere primarily operates in the Health Tech & Life Sciences sector, with a focus on Medical Devices and Diagnostics Devices.